Insider Trading History of Hemmi Gregory

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Hemmi Gregory since 2011. The trader's CIK number is 1507649. At the time of the last reporting, Hemmi Gregory was the VP Chemical Operations of Pharmacyclics Inc. (stock ticker symbol PCYC). Also see all insider trading activities at Pharmacyclics Inc.


Yearly summary of insider trading at Pharmacyclics Inc (PCYC) by Hemmi Gregory

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2014 PCYC 0 $0 15,000 $2,100,030 28,000 $22,650
2013 PCYC 0 $0 75,000 $6,944,030 75,000 $132,165
2012 PCYC 0 $0 31,125 $1,043,693 33,000 $224,517
2011 PCYC 0 $0 0 $0 6,000 $4,500


Insider trading of Pharmacyclics Inc (PCYC) by Hemmi Gregory

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2014-03-05 PCYC Option Ex 15,000 .86 12,900
2014-03-05 PCYC Sale 15,000 140.00 2,100,030
2013-12-30 PCYC Option Ex 13,000 .75 9,750
2013-12-18 PCYC Option Ex 10,000 .86 8,600
2013-12-17 PCYC Sale 10,000 102.00 1,020,000
2013-12-18 PCYC Sale 10,000 99.04 990,380
2013-12-17 PCYC Option Ex 10,000 .86 8,600
2013-05-31 PCYC Option Ex 50,000 1.81 90,500
2013-05-31 PCYC Sale 50,000 91.96 4,598,100
2013-01-11 PCYC Option Ex 5,000 4.89 24,465
2013-01-11 PCYC Sale 5,000 67.11 335,550
2012-12-26 PCYC Option Ex 100 4.47 447
2012-12-27 PCYC Option Ex 12,900 7.84 101,136
2012-12-26 PCYC Sale 100 59.00 5,900
2012-12-27 PCYC Sale 12,900 59.50 767,550
2012-05-08 PCYC Option Ex 1,875 4.25 7,968
2011-12-30 PCYC Option Ex 18,125 6.34 114,966
2011-12-30 PCYC Sale 18,125 14.91 270,243
2011-07-13 PCYC Option Ex 6,000 .75 4,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hemmi Gregory (VP Chemical Operations of Pharmacyclics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.